Home » me » Lista Pubs Lancet

Lista Pubs Lancet

Lancet Methodological-Statistical Series

Series – Epidemiology 2005

http://www.thelancet.com/collections/series/epidemiology

  • Sample size calculations in randomised trials: mandatory and mystical. Kenneth F Schulz, David A Grimes – 9 April 2005 (Vol. 365, Issue 9467, pages 1348-1353)
    Summary | Full Text

  • Compared to what? Finding controls for case-control studies. David A Grimes, Kenneth F Schulz – 16 April 2005 (Vol. 365, Issue 9468, pages 1429-1433)
    Summary | Full Text

  • Refining clinical diagnosis with likelihood ratios. David A Grimes, Kenneth F Schulz – 23 April 2005 (Vol. 365, Issue 9469, pages 1500-1505)
    Summary | Full Text

  • Multiplicity in randomised trials I: endpoints and treatments. Kenneth F Schulz, David A Grimes – 30 April 2005 (Vol. 365, Issue 9470, pages 1591-1595)
    Summary | Full Text

  • Multiplicity in randomised trials II: subgroup and interim analyses. Kenneth F Schulz, David A Grimes – 7 May 2005 (Vol. 365, Issue 9471, pages 1657-1661)
    Summary | Full Text

 

Series – Treating Individuals

  • Evidence-based practice and the individual. Summerskill W – 01 January 2005 (Vol. 365, Issue 9453, pages 13-14). Full Text

  • External validity of randomised controlled trials: “To whom do the results of this trial apply?”. Rothwell PM – 01 January 2005 (Vol. 365, Issue 9453, pages 82-93) Summary | Full Text

  • Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Rothwell PM – 08 January 2005 (Vol. 365, Issue 9454, pages 176-186) Summary | Full Text

  • From subgroups to individuals: general principles and the example of carotid endarterectomy. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP – 15 January 2005 (Vol. 365, Issue 9455, pages 256-265). Summary | Full Text

  • Can meta-analysis help target interventions at individuals most likely to benefit?. Thompson SG, Higgins JP – 22 January 2005 (Vol. 365, Issue 9456, pages 341-346). Summary | Full Text

  • Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Jackson R, Lawes CM,  Bennett DA, Milne RJ, Rodgers A – 29 January 2005 (Vol. 365, Issue 9457, pages 434-441). Summary | Full Text

2002

  • Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359(9306):614-618 [Full text PDF].

  • Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002;359(9307):696-700 [Summary].

  • Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet 2002;359(9304):431-434 [Summary].

  • Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet 2002;359(9303):341-345 [Full Text PDF].

  • Grimes DA, Schulz KF. Descriptive studies: what they can and cannot do. Lancet 2002;359(9301):145-149 [Summary].

  • Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002;359(9305):515-519 [Summary].

  • Grimes DA, Schulz KF. An overview of clinical research: the lay of the land. Lancet 2002;359(9300):57-61 [Full Text PDF].

  • Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002;359(9308):781-785 [Summary].

  • Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet 2002;359(9310):966-970 [Summary].

  • Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359(9309):881-884 [Summary].

  • Sass JO, Pascoe-González S, Lehnert W, Grimes D, Schulz K. Screening in clinical trials [letters]. Lancet 2002;360(9337):952 [Full Text].

  • Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002;359(9302):248-252 [Summary].

 

2005

  • Sample size calculations in randomised trials: mandatory and mystical. Schulz KF, Grimes DA – 09 April 2005 (Vol. 365, Issue 9467, pages 1348-1353). Summary | Full Text

  • Compared to what? Finding controls for case-control studies. Grimes DA, Schulz KF – 16 April 2005 (Vol. 365, Issue 9468, pages 1429-1433). Summary | Full Text

  • Refining clinical diagnosis with likelihood ratios. Grimes DA, Schulz KF – 23 April 2005 (Vol. 365, Issue 9469, pages 1500-1505). Summary | Full Text

  • Multiplicity in randomised trials I: endpoints and treatments. Schulz KF, Grimes DA – 30 April 2005 (Vol. 365, Issue 9470, pages 1591-1595). Summary | Full Text

  • Multiplicity in randomised trials II: subgroup and interim analyses. Schulz KF, Grimes DA – 07 May 2005 (Vol. 365, Issue 9471, pages 1657-1661). Summary | Full Text

Ir a inicio

 

Series – Genetic Epidemiology
  • Genetic epidemiology and public health: hope, hype, and future prospects. Smith GD, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR – 22 October 2005 (Vol. 366, Issue 9495, pages 1484-1498). Summary | Full Text

  • Population-based family studies in genetic epidemiology. Hopper JL, Bishop DT, Easton DF – 15 October 2005 (Vol. 366, Issue 9494, pages 1397-1406. Summary | Full Text

  • What makes a good genetic association study?. Hattersley AT, McCarthy MI – 08 October 2005 (Vol. 366, Issue 9493, pages 1315-1323). Summary | Full Text

  • Shaking the tree: mapping complex disease genes with linkage disequilibrium. Palmer LJ, Cardon LR – 01 October 2005 (Vol. 366, Issue 9492, pages 1223-1234). Summary | Full Text

  • Genetic association studies. Cordell HJ, Clayton DG – 24 September 2005 (Vol. 366, Issue 9491, pages 1121-1131). Summary | Full Text

  • Genetic linkage studies. Dawn Teare M, Barrett JH – 17 September 2005 (Vol. 366, Issue 9490, pages 1036-1044). Summary | Full Text

  • Key concepts in genetic epidemiology. Burton PR, Tobin MD, Hopper JL – 10 September 2005 (Vol. 366, Issue 9489, pages 941-951). Summary | Full Text

Ir a inicio

Otros:

  • Horton R. From star signs to trial guidelines. Lancet 2000; 355: 1033–34.

  • Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other mis(uses) of baseline data in clinical trials. Lancet 2000; 255: 1064-1069.